Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Immunophilins are a family of proteins whose signature domain is the peptidylprolyl-isomerase domain. High molecular weight immunophilins are characterized by the additional presence of tetratricopeptide-repeats (TPR) through which they bind to the 90-kDa heat-shock protein (Hsp90), and via this chaperone, immunophilins contribute to the regulation of the biological functions of several client-proteins. Among these Hsp90-binding immunophilins, there are two highly homologous members named FKBP51 and FKBP52 (FK506-binding protein of 51-kDa and 52-kDa, respectively) that were first characterized as components of the Hsp90-based heterocomplex associated to steroid receptors. Afterwards, they emerged as likely contributors to a variety of other hormone-dependent diseases, stress-related pathologies, psychiatric disorders, cancer, and other syndromes characterized by misfolded proteins. The differential biological actions of these immunophilins have been assigned to the structurally similar, but functionally divergent enzymatic domain. Nonetheless, they also require the complementary input of the TPR domain, most likely due to their dependence with the association to Hsp90 as a functional unit. FKBP51 and FKBP52 regulate a variety of biological processes such as steroid receptor action, transcriptional activity, protein conformation, protein trafficking, cell differentiation, apoptosis, cancer progression, telomerase activity, cytoskeleton architecture, etc. In this article we discuss the biology of these events and some mechanistic aspects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“Like SRs, NF-κB dimers are also subject of a dynamic nuclear-cytoplasmic shuttling [117,118].”
BackgroundThe PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749 · cited 1×
“PI3K activity is essential for AKT relocalization to the plasma membrane [130,131].”
BackgroundAdipocyte differentiation from the inside out
Rosen, E. D., & MacDougald, O. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2066 · Cited by 2,607 · cited 1×
“This observation may be related to the fact that adipogenesis is regulated by signaling pathways that coordinately modulate the sequential activation of transcription factors required for cells to differentiate [196].”
BackgroundFat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857 · cited 1×
“Actually, the biological action of estrogen ligands as risk factors for developing tumors depends primarily on the balance between these two receptors [168], as well as on the high levels of exposure to estrogens”
BackgroundSchopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 2×
“Genetic variants of the fkbp5 gene encoding for FKBP51 protein have been consistently associated in humans with psychiatric disorders related to post-traumatic events [20,85,215,216].”
BackgroundTelomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.016 · Cited by 709
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622 · cited 1×
“Because it represses GR activity [212], this is traduced in an amplification of the stress response if the stimulation is prolonged, which influences several aspects of neuronal function and the tissue synaptic plasticity [213,214].”
BackgroundMostaghel, E. A., Page, S. T., Lin, D. W., Fazli, L., Coleman, I. M., True, L. D., Knudsen, B., Hess, D. L., Nelson, C. C., Matsumoto, A. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3332 · Cited by 529
Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4
Stepanova, L., Leng, X., Parker, S. B., & Harper, J. W. (1996) · Genes & Development · doi:10.1101/gad.10.12.1491 · Cited by 483 · cited 1×
“FKBP51 is involved with this process because it forms heterocomplexes with the cyclin-dependent kinase Cdk4, a kinase whose enzymatic activity is modulated by Hsp90 heterocomplexes [209,210].”
BackgroundA New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427 · cited 2×
“When the steroid binds, FKBP51 is exchanged by FKBP52 due to a ligand-induced conformational change of the receptor [52].”
BackgroundAtomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase
Verba, K. A., Wang, R. Y.-R., Arakawa, A., Liu, Y., Shirouzu, M., Yokoyama, S., & Agard, D. A. (2016) · Science · doi:10.1126/science.aaf5023 · Cited by 424
The Hsp90‐binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo
Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung‐Flynn, J., Prapapanich, V., Ratajczak, T., Gaber, R., Picard, D., & Smith, D. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg108 · Cited by 353 · cited 2×
“) [107] Hepatocarcinoma ↓ ↑ [112,113] Colorectal carcinoma ↑ ↑ [110,176] Lymphoma ↑ ↑ [162,177] Nervous System Neurodifferentiation ↓ ↑ [178] Neuroregeneration ↓ ↑ [179] Astrocytoma ↑ ↑ [180–182] Myoblast differentiation ↑(*) ↓ [183] Adipogenesis ↑ ↓ [141] Steroid receptors GR ↓ ↑ [18,86] MR ↓ N [56,184] PR ↓ ↑ [185,1…”
BackgroundMechanisms of Brain Iron Transport: Insight into Neurodegeneration and CNS Disorders
Mills, E., Dong, X.-P., Wang, F., & Xu, H. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.09.140 · Cited by 309 · cited 1×
“If this observation is correct, it may be of therapeutic interest since alterations in metal homeostasis have been related to several neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, and also prion diseases [193,194].”
BackgroundZheng, W., & Monnot, A. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.006 · Cited by 302 · cited 1×
“If this observation is correct, it may be of therapeutic interest since alterations in metal homeostasis have been related to several neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, and also prion diseases [193,194].”
BackgroundRole of hsp90 and the hsp90-binding immunophilins in signalling protein movement
Pratt, W. B., Galigniana, M. D., Harrell, J. M., & DeFranco, D. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.02.004 · Cited by 285 · cited 1×
“Due to amino acid charge complementation, this region is the same that has been postulated as an FKBP52 interacting domain with steroid receptors [44,78].”
BackgroundSelf-citationFKBP51 and FKBP52 in signaling and disease
Storer, C. L., Dickey, C. A., Galigniana, M. D., Rein, T., & Cox, M. B. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.08.001 · Cited by 266 · cited 3×
“The binding of Hsp90 to the immunophilin enables the FK1 domain to interact with the ligand binding domain of the glucocorticoid receptor (GR), thereby influencing the GR conformation and the steroid binding affinity [24].”
BackgroundInfluentialSelf-citationSinars, C. R., Cheung-Flynn, J., Rimerman, R. A., Scammell, J. G., Smith, D. F., & Clardy, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0231020100 · Cited by 254 · cited 2×
“Inasmuch as the conformations of the FK1 domains of both FKBPs differ around the PPIase pocket, it is not surprising that this fact causes differential protein interactions with client-factors [25,26].”
BackgroundSelective inhibitors of the FK506-binding protein 51 by induced fit
Gaali, S., Kirschner, A., Cuboni, S., Hartmann, J., Kozany, C., Balsevich, G., Namendorf, C., Fernandez-Vizarra, P., Sippel, C., Zannas, A. S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1699 · Cited by 245 · cited 4×
“In this regard, the recent development of synthetic small molecules able to selectively prevent the PPIase activity without showing immunosuppressive action represents a promising pharmacologic alternative to be explored [61,151].”
BackgroundMethodInfluentialGaligniana, M. D., Radanyi, C., Renoir, J.-M., Housley, P. R., & Pratt, W. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010809200 · Cited by 236 · cited 2×
“The discovery that the dynein/dynactin motor complex co-immunoprecipitates with GR [41] and MR [42] via its association to the PPIase domain of FKBP52 modified the classic view for the mechanism of steroid receptor activation.”
BackgroundSelf-citationPhysiological role for the cochaperone FKBP52 in androgen receptor signaling
Cheung-Flynn, J., Prapapanich, V., Cox, M. B., Riggs, D. L., Suarez-Quian, C., & Smith, D. F. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0071 · Cited by 212
Barent, R. L., Nair, S. C., Carr, D. C., Ruan, Y., Rimerman, R. A., Fulton, J., Zhang, Y., & Smith, D. F. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0075 · Cited by 190 · cited 11×
“It is accepted that CyP40 is the critical immunophilin of the complex because its knock-down decreases the viability of ALK+ ALCL cell lines, an effect that cannot be achieved after knocking down FKBP51 or FKBP52.”
BackgroundInfluentialReynolds, P. D., Ruan, Y., Smith, D. F., & Scammell, J. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5429 · Cited by 184
Pirkl, F., & Buchner, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4595 · Cited by 179
Wu, B., Li, P., Liu, Y., Lou, Z., Ding, Y., Shu, C., Ye, S., Bartlam, M., Shen, B., & Rao, Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305969101 · Cited by 165
Ni, L., Yang, C.-S., Gioeli, D., Frierson, H., Toft, D. O., & Paschal, B. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01891-08 · Cited by 155 · cited 1×
“Accordingly, the overexpression of FKBP51 favours prostate cancer cell growth and impairs the effectiveness of antiandrogen therapies, for example, treatments with bicalutamide, that is frequently used in patients undergoing androgen ablation therapy [94].”
BackgroundGaligniana, M. D., Erlejman, A. G., Monte, M., Gomez-Sanchez, C., & Piwien-Pilipuk, G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01190-09 · Cited by 152
Self-citationRiggs, D. L., Cox, M. B., Tardif, H. L., Hessling, M., Buchner, J., & Smith, D. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00985-07 · Cited by 150 · cited 1×
“Although the PPIase activity is not necessary for enhancing AR activity, the FK1 catalytic pocket appears to be essential in potentiating the AR response to androgens via [105], such that treatments with FK506 reduce AR binding capacity and prevents the androgen-induced proliferation of prostate cancer cells.”
BackgroundHsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus
Galigniana, M. D., Harrell, J. M., O'Hagen, H. M., Ljungman, M., & Pratt, W. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402223200 · Cited by 150
Hubler, T. R., Denny, W. B., Valentine, D. L., Cheung-Flynn, J., Smith, D. F., & Scammell, J. G. (2003) · Endocrinology · doi:10.1210/en.2003-0092 · Cited by 145
Echeverría, P. C., Mazaira, G., Erlejman, A., Gomez-Sanchez, C., Pilipuk, G. P., & Galigniana, M. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00649-09 · Cited by 144 · cited 1×
“When the key role for FKBP52 in the receptor retrograde movement was demonstrated, the classic dogma was replaced by a model where the entire receptor•Hsp90•FKBP52•dynein complex moves throughout the cytoplasm, translocates intact through the nuclear pore, and is finally dissociated in the nucleoplasm [42,48] (Figure…”
BackgroundSelf-citationA role for FKBP52 in tau protein function
Chambraud, B., Sardin, E., Giustiniani, J., Dounane, O., Schumacher, M., Goedert, M., & Baulieu, E.-E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914957107 · Cited by 140
De Leon, J. T., Iwai, A., Feau, C., Garcia, Y., Balsiger, H. A., Storer, C. L., Suro, R. M., Garza, K. M., Lee, S., Sang Kim, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105160108 · Cited by 132
Tatro, E. T., Everall, I. P., Kaul, M., & Achim, C. L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.036 · Cited by 125
Lin, J., Xu, J., Tian, H., Gao, X., Chen, Q., Gu, Q., Xu, G., Song, J., & Zhao, F. (2007) · International Journal of Cancer · doi:10.1002/ijc.23016 · Cited by 125
Miyata, Y., Chambraud, B., Radanyi, C., Leclerc, J., Lebeau, M.-C., Renoir, J.-M., Shirai, R., Catelli, M.-G., Yahara, I., & Baulieu, E.-E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14500 · Cited by 121
Galigniana, M. D., Echeverría, P. C., Erlejman, A. G., & Piwien-Pilipuk, G. (2010) · Nucleus · doi:10.4161/nucl.1.4.11743 · Cited by 114 · cited 2×
“According to the novel model, the competitive balance between dynein-binding immunophilins versus non-dynein-binding TPR proteins associated to the receptor•Hsp90 complex may influence the basal subcellular redistribution of the receptor [42,54].”
BackgroundSelf-citationPharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties
Hartmann, J., Wagner, K. V., Gaali, S., Kirschner, A., Kozany, C., Ruhter, G., Dedic, N., Hausl, A. S., Hoeijmakers, L., Westerholz, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4024-14.2015 · Cited by 109 · cited 2×
“In these cases, homozygous individuals show an anomalous normalization of the stress-induced cortisol secretion [217,218] and a male-specific effects of the variant rs3800374 to respond to acute psychosocial stress was also found in healthy individuals [219].”
BackgroundPeriyasamy, S., Hinds, T., Shemshedini, L., Shou, W., & Sanchez, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.458 · Cited by 108 · cited 13×
“It is accepted that CyP40 is the critical immunophilin of the complex because its knock-down decreases the viability of ALK+ ALCL cell lines, an effect that cannot be achieved after knocking down FKBP51 or FKBP52.”
BackgroundResultInfluentialAndrogen mediated regulation and functional implications of FKBP51 expression in prostate cancer
FEBBO, P. G., LOWENBERG, M., THORNER, A. R., BROWN, M., LODA, M., & GOLUB, T. R. (2005) · Journal of Urology · doi:10.1097/01.ju.0000155845.44729.ba · Cited by 99
FKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92 · cited 1×
“Several studies have demonstrated that FKBPs are important for the initiation and progression of various types of cancer, as well as for potential treatments of endocrine-related diseases through perturbation of the steroid receptor signaling cascade (see [106,152,153] for recent reviews).”
BackgroundWestberry, J. M., Sadosky, P. W., Hubler, T. R., Gross, K. L., & Scammell, J. G. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.004 · Cited by 91
Jiang, W., Cazacu, S., Xiang, C., Zenklusen, J. C., Fine, H. A., Berens, M., Armstrong, B., Brodie, C., & Mikkelsen, T. (2008) · Neoplasia · doi:10.1593/neo.07929 · Cited by 88
Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52)
Sivils, J. C., Storer, C. L., Galigniana, M. D., & Cox, M. B. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.010 · Cited by 81 · cited 2×
“Accordingly, it has recently been postulated that the loop serves as an interaction surface with the ligand binding domain of the receptor [28,29].”
BackgroundSelf-citationPeriyasamy, S., Warrier, M., Tillekeratne, M. P. M., Shou, W., & Sanchez, E. R. (2007) · Endocrinology · doi:10.1210/en.2007-0145 · Cited by 78 · cited 5×
“Importantly, the macrolide FK506 inhibits androgen-induced cell proliferation [90], an effect abolished by the FKBP51 knock-down, but not by FKBP52 knock-down [101,102].”
BackgroundResultInfluentialTargeting the glucocorticoid receptor in breast and prostate cancers
Kach, J., Conzen, S. D., & Szmulewitz, R. Z. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7531 · Cited by 74 · cited 1×
“A direct consequence of these properties is that the glucocorticoid-activated GR can attenuate the biological actions of androgen-activated AR genes, suggesting an AR-dependent mechanism where GR can actually function as a tumour suppressor in cases of prostate cancer [97,98].”
BackgroundFunction of Cytosolic Chaperones in Tom70-Mediated Mitochondrial Import
C.Y. Fan, A., & C. Young, J. (2011) · Protein & Peptide Letters · doi:10.2174/092986611794475020 · Cited by 64
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Gassen, N. C., Hartmann, J., Zannas, A. S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L. K., Wagner, K. V., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.38 · Cited by 62
Warrier, M., Hinds, T. D., Ledford, K. J., Cash, H. A., Patel, P. R., Bowman, T. A., Stechschulte, L. A., Yong, W., Shou, W., Najjar, S. M., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1158 · Cited by 57 · cited 2×
“This process first demonstrated in cell lines is also evidenced by Western blot analysis in mice samples of adipose tissue [195].”
BackgroundKlengel, T., & Binder, E. B. (2013) · Epigenomics · doi:10.2217/epi.13.11 · Cited by 52
Sabbagh, J. J., Cordova, R. A., Zheng, D., Criado-Marrero, M., Lemus, A., Li, P., Baker, J. D., Nordhues, B. A., Darling, A. L., Martinez-Licha, C., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00454 · Cited by 48 · cited 2×
“In this regard, the recent development of synthetic small molecules able to selectively prevent the PPIase activity without showing immunosuppressive action represents a promising pharmacologic alternative to be explored [61,151].”
BackgroundPromotion of Myoblast Differentiation by Fkbp5 via Cdk4 Isomerization
Ruiz-Estevez, M., Staats, J., Paatela, E., Munson, D., Katoku-Kikyo, N., Yuan, C., Asakura, Y., Hostager, R., Kobayashi, H., Asakura, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.006 · Cited by 39 · cited 10×
“FKBP51 is involved with this process because it forms heterocomplexes with the cyclin-dependent kinase Cdk4, a kinase whose enzymatic activity is modulated by Hsp90 heterocomplexes [209,210].”
BackgroundInfluentialThe helix 1–3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones
Cluning, C., Ward, B. K., Rea, S. L., Arulpragasam, A., Fuller, P. J., & Ratajczak, T. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1023 · Cited by 26
Research works printed but not linked: 172
- 2015, Multidomain Peptidyl Prolyl cis/trans Isomerases, Biochim. Biophys. Acta, 1850, 2005, 10.1016/j.bbagen.2014.11.012 · DOI
- Kang, 2008, FKBP family proteins: Immunophilins with versatile biological functions, Neurosignals, 16, 318, 10.1159/000123041 · DOI · Paper page
- Kino, 1987, FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro, J. Antibiot., 40, 1256, 10.7164/antibiotics.40.1256 · DOI · Paper page
- Kino, 1987, FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics, J. Antibiot., 40, 1249, 10.7164/antibiotics.40.1249 · DOI · Paper page
- Ruegger, 1976, [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity], Helv. Chim. Acta, 59, 1075, 10.1002/hlca.19760590412 · DOI · Paper page
- John Wiley & Sons (2005). Ciclosporin. Drug Discovery—A History, John Wiley & Sons.
- Hanes, 2015, Prolyl isomerases in gene transcription, Biochim. Biophys. Acta, 1850, 2017, 10.1016/j.bbagen.2014.10.028 · DOI
- Matena, 2018, Structure and function of the human parvulins Pin1 and Par14/17, Biol. Chem., 399, 101, 10.1515/hsz-2017-0137 · DOI
- Barik, S. (2018). Dual-Family Peptidylprolyl Isomerases (Immunophilins) of Select Monocellular Organisms. Biomolecules. · doi:10.20944/preprints201810.0616.v1
- Netzer, 1997, Recombination of protein domains facilitated by co-translational folding in eukaryotes, Nature, 388, 343, 10.1038/41024 · DOI · Paper page
- Helbig, 2011, Activation of colicin M by the FkpA prolyl cis-trans isomerase/chaperone, J. Biol. Chem., 286, 6280, 10.1074/jbc.M110.165274 · DOI
- Theuerkorn, 2011, Prolyl cis/trans isomerase signalling pathways in cancer, Curr. Opin. Pharmacol., 11, 281, 10.1016/j.coph.2011.03.007 · DOI
- Li, 2009, Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones, Br. J. Pharmacol., 158, 1904, 10.1111/j.1476-5381.2009.00482.x · DOI
- Li, 2011, Interaction of calcineurin with substrates and targeting proteins, Trends Cell Biol., 21, 91, 10.1016/j.tcb.2010.09.011 · DOI · Paper page
- Callebaut, 1992, An immunophilin that binds M(r) 90,000 heat shock protein: Main structural features of a mammalian p59 protein, Proc. Natl. Acad. Sci. USA, 89, 6270, 10.1073/pnas.89.14.6270 · DOI · Paper page
- Smith, 2004, Tetratricopeptide repeat cochaperones in steroid receptor complexes, Cell Stress Chaperones, 9, 109, 10.1379/CSC-31.1 · DOI
- Riggs, 2004, Functional specificity of co-chaperone interactions with Hsp90 client proteins, Crit. Rev. Biochem. Mol. Biol., 39, 279, 10.1080/10409230490892513 · DOI · Paper page
- Fries, G.R., Gassen, N.C., and Rein, T. (2017). The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease. Int. J. Mol. Sci., 18. · DOI · Paper page
- Galigniana, 2018, Structural characteristics of the TPR protein-Hsp90 interaction: A new target in biotechnology, Role of Molecular Chaperones in Structural Folding, Biological Actions, and Drug Interactions of Client Proteins, Volume 1, 73
- LeMaster, 2015, Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins, J. Biol. Chem., 290, 15746, 10.1074/jbc.M115.650655 · DOI
- Guy, 2015, Functions of the Hsp90-binding FKBP immunophilins, Subcell. Biochem., 78, 35, 10.1007/978-3-319-11731-7_2 · DOI · Paper page
- Mazaira, 2018, Gene expression regulation by heat-shock proteins: The cardinal roles of HSF1 and Hsp90, Biochem. Soc. Trans., 46, 51, 10.1042/BST20170335 · DOI
- Pratt, 1997, The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase, Annu. Rev. Pharm. Toxicol., 37, 297, 10.1146/annurev.pharmtox.37.1.297 · DOI · Paper page
- Mazaira, 2018, The Nuclear Receptor Field: A Historical Overview and Future Challenges, Nucl. Recept. Res., 5, 101320, 10.11131/2018/101320 · DOI
- Pratt, 1997, Steroid receptor interactions with heat shock protein and immunophilin chaperones, Endocr. Rev., 18, 306
- Auricchio, 1989, Phosphorylation of steroid receptors, J. Steroid Biochem., 32, 613, 10.1016/0022-4731(89)90397-X · DOI
- Galigniana, 1998, Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases, Biochem. J., 333, 555, 10.1042/bj3330555 · DOI · Paper page
- McGuinness, 2016, Posttranslational Modifications of Steroid Receptors: Phosphorylation, Methods Mol. Biol., 1443, 105, 10.1007/978-1-4939-3724-0_7 · DOI
- Harrell, 2002, All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells, Biochemistry, 41, 5581, 10.1021/bi020073q · DOI · Paper page
- Pratt, 2001, Hsp90-binding immunophilins in plants: The protein movers, Trends Plant Sci., 6, 54, 10.1016/S1360-1385(00)01843-4 · DOI
- Erlejman, 2014, Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression, Biochim. Biophys. Acta, 1839, 71, 10.1016/j.bbagrm.2013.12.006 · DOI
- Darshan, 2011, Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer, Cancer Res., 71, 6019, 10.1158/0008-5472.CAN-11-1417 · DOI · Paper page
- Yang, 1997, Subnuclear trafficking of glucocorticoid receptors in vitro: Chromatin recycling and nuclear export, J. Cell Biol., 137, 523, 10.1083/jcb.137.3.523 · DOI · Paper page
- Fu, X., Liang, C., Li, F., Wang, L., Wu, X., Lu, A., Xiao, G., and Zhang, G. (2018). The Rules and Functions of Nucleocytoplasmic Shuttling Proteins. Int. J. Mol. Sci., 19. · DOI
- Mazaira, 2014, The Emerging Role of TPR-Domain Immunophilins in the Mechanism of Action of Steroid Receptors, Nucl. Recept. Res., 1, 1, 10.11131/2014/101094 · DOI
- Presman, D.M., Alvarez, L.D., Levi, V., Eduardo, S., Digman, M.A., Marti, M.A., Veleiro, A.S., Burton, G., and Pecci, A. (2010). Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids. PLoS ONE, 5. · DOI
- Grossmann, 2012, Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling, Chem. Biol., 19, 742, 10.1016/j.chembiol.2012.04.014 · DOI
- Silverstein, 1997, Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin, J. Biol. Chem., 272, 16224, 10.1074/jbc.272.26.16224 · DOI · Paper page
- Madan, 1993, Bidirectional transport of glucocorticoid receptors across the nuclear envelope, Proc. Natl. Acad. Sci. USA, 90, 3588, 10.1073/pnas.90.8.3588 · DOI · Paper page
- Galigniana, 2012, Steroid receptor coupling becomes nuclear, Chem. Biol., 19, 662, 10.1016/j.chembiol.2012.06.001 · DOI
- Gallo, 2007, Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity, Biochemistry, 46, 14044, 10.1021/bi701372c · DOI · Paper page
- Erlejman, 2014, Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52, Curr. Protein Pept. Sci., 15, 205, 10.2174/1389203715666140331113753 · DOI
- Ratajczak, 2015, Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling, Clin. Biochem. Rev., 36, 31
- Oroz, 2018, Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex, Nat. Commun., 9, 4532, 10.1038/s41467-018-06880-0 · DOI · Paper page
- Echeverria, 2010, Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility, Biochim. Biophys. Acta, 1803, 641, 10.1016/j.bbamcr.2009.11.012 · DOI · Paper page
- Ebong, 2016, The interchange of immunophilins leads to parallel pathways and different intermediates in the assembly of Hsp90 glucocorticoid receptor complexes, Cell Discov., 2, 16002, 10.1038/celldisc.2016.2 · DOI · Paper page
- Vandevyver, 2012, On the trail of the glucocorticoid receptor: Into the nucleus and back, Traffic, 13, 364, 10.1111/j.1600-0854.2011.01288.x · DOI · Paper page
- Jeong, 2016, Hsp90-binding immunophilin FKBP52 modulates telomerase activity by promoting the cytoplasmic retrotransport of hTERT, Biochem. J., 473, 3517, 10.1042/BCJ20160344 · DOI
- Vafopoulou, 2012, Cytoplasmic travels of the ecdysteroid receptor in target cells: Pathways for both genomic and non-genomic actions, Front. Endocrinol., 3, 43, 10.3389/fendo.2012.00043 · DOI
- Schuster, 2017, The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells, Sci. Rep., 7, 613, 10.1038/s41598-017-00780-x · DOI
- Erlejman, 2014, NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A role for peptidyl-prolyl isomerase activity, J. Biol. Chem., 289, 26263, 10.1074/jbc.M114.582882 · DOI · Paper page
- Colo, 2008, The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action, Oncogene, 27, 2430, 10.1038/sj.onc.1210900 · DOI
- Lagadari, 2016, Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity, Mol. Oncol., 10, 1086, 10.1016/j.molonc.2016.05.002 · DOI
- McKeen, 2008, A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling, Endocrinology, 149, 5724, 10.1210/en.2008-0168 · DOI · Paper page
- Nair, 1997, Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor, Mol. Cell. Biol., 17, 594, 10.1128/MCB.17.2.594 · DOI · Paper page
- Ratajczak, 1990, Isolation of untransformed bovine estrogen receptor without molybdate stabilization, J. Steroid Biochem., 35, 543, 10.1016/0022-4731(90)90197-Z · DOI
- Portella, 2014, Androgen receptor splice variants determine taxane sensitivity in prostate cancer, Cancer Res., 74, 2270, 10.1158/0008-5472.CAN-13-2876 · DOI · Paper page
- Pratt, 1993, The hsp56 immunophilin component of steroid receptor heterocomplexes: Could this be the elusive nuclear localization signal-binding protein?, J. Steroid Biochem. Mol. Biol., 46, 269, 10.1016/0960-0760(93)90216-J · DOI
- Jhaveri, 2014, Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions, Expert Opin. Investig. Drugs, 23, 611, 10.1517/13543784.2014.902442 · DOI · Paper page
- Chatterjee, S., and Burns, T.F. (2017). Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. Int. J. Mol. Sci., 18. · DOI · Paper page
- Inda, 2016, Stressing Out Hsp90 in Neurotoxic Proteinopathies, Curr. Top. Med. Chem., 16, 2829, 10.2174/1568026616666160413141350 · DOI
- Denny, 2000, Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding, Endocrinology, 141, 4107, 10.1210/endo.141.11.7785 · doi:10.1210/endo.141.11.7785 · Paper page
- Ward, 1999, Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer, Breast Cancer Res. Treat., 58, 267, 10.1023/A:1006390804515 · DOI
- Ratajczak, 2015, Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease, Curr. Mol. Pharmacol., 9, 66, 10.2174/1874467208666150519113639 · DOI
- Gougelet, 2005, Estrogen receptor α and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells, J. Steroid Biochem. Mol. Biol., 94, 71, 10.1016/j.jsbmb.2005.01.018 · DOI
- Wu, 2016, The environmental endocrine disruptor p-nitrophenol interacts with FKBP51, a positive regulator of androgen receptor and inhibits androgen receptor signaling in human cells, J. Hazard. Mater., 307, 193, 10.1016/j.jhazmat.2015.12.045 · DOI
- Joshi, 2017, Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52, Mol. Oncol., 11, 337, 10.1002/1878-0261.12028 · DOI
- Sahu, 2013, FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells, Cancer Res., 73, 1570, 10.1158/0008-5472.CAN-12-2350 · DOI · Paper page
- Yemelyanov, 2007, Tumor suppressor activity of glucocorticoid receptor in the prostate, Oncogene, 26, 1885, 10.1038/sj.onc.1209991 · DOI
- Leach, 2017, The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome, Prostate, 77, 185, 10.1002/pros.23259 · DOI
- Yong, 2007, Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology, J. Biol. Chem., 282, 5026, 10.1074/jbc.M609360200 · DOI · Paper page
- Yeh, 2002, Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues, Proc. Natl. Acad. Sci. USA, 99, 13498, 10.1073/pnas.212474399 · DOI · Paper page
- Sanchez, 2012, Chaperoning steroidal physiology: Lessons from mouse genetic models of Hsp90 and its cochaperones, Biochim. Biophys. Acta, 1823, 722, 10.1016/j.bbamcr.2011.11.006 · DOI · Paper page
- Solassol, 2011, FKBP family proteins as promising new biomarkers for cancer, Curr. Opin. Pharmacol., 11, 320, 10.1016/j.coph.2011.03.012 · DOI
- Russo, D., Merolla, F., Mascolo, M., Ilardi, G., Romano, S., Varricchio, S., Napolitano, V., Celetti, A., Postiglione, L., and Di Lorenzo, P.P. (2017). FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?. Int. J. Mol. Sci., 18. · DOI
- Bonner, 2017, Diverse structures, functions and uses of FK506 binding proteins, Cell Signal., 38, 97, 10.1016/j.cellsig.2017.06.013 · DOI
- Huang, 2015, Silencing of Taxol-Sensitizer Genes in Cancer Cells: Lack of Sensitization Effects, Cancers, 7, 1052, 10.3390/cancers7020824 · DOI
- Rotoli, 2016, Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy, Oncol. Lett., 12, 1315, 10.3892/ol.2016.4772 · DOI
- Rotoli, D., Morales, M., Avila, J., Maeso, M.D.C., Garcia, M.D.P., Mobasheri, A., and Martin-Vasallo, P. (2017). Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy. Int. J. Mol. Sci., 18. · DOI
- Liu, 2010, Proteomic mining in the dysplastic liver of WHV/c-myc mice--insights and indicators for early hepatocarcinogenesis, FEBS J., 277, 4039, 10.1111/j.1742-4658.2010.07795.x · DOI
- Xu, 2016, The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals, EBioMedicine, 12, 55, 10.1016/j.ebiom.2016.07.013 · DOI
- Sun, 2017, The non-canonical NF-κB pathway in immunity and inflammation, Nat. Rev. Immunol., 17, 545, 10.1038/nri.2017.52 · DOI · Paper page
- Gilmore, 2006, Introduction to NF-κB: Players, pathways, perspectives, Oncogene, 25, 6680, 10.1038/sj.onc.1209954 · DOI · Paper page
- Mackenzie, 2006, Microtubules are required for NF-κB nuclear translocation in neuroblastoma IMR-32 cells: Modulation by zinc, J. Neurochem., 99, 402, 10.1111/j.1471-4159.2006.04005.x · DOI
- Gojoubori, 2016, Electrolytically generated acid functional water inhibits NF-κB activity by attenuating nuclear-cytoplasmic shuttling of p65 and p50 subunits, J. Recept. Signal Transduct. Res., 36, 248, 10.3109/10799893.2015.1086883 · DOI
- Ryo, 2003, Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA, Mol. Cell, 12, 1413, 10.1016/S1097-2765(03)00490-8 · DOI · Paper page
- Wulf, 2003, The prolyl isomerase Pin1 in breast development and cancer, Breast Cancer Res., 5, 76, 10.1186/bcr572 · DOI · Paper page
- Wulf, 2001, Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1, EMBO J., 20, 3459, 10.1093/emboj/20.13.3459 · DOI · Paper page
- Bao, 2004, Prevalent overexpression of prolyl isomerase Pin1 in human cancers, Am. J. Pathol., 164, 1727, 10.1016/S0002-9440(10)63731-5 · DOI · Paper page
- Yoshimura, 2003, Negative regulation of cytokine signaling influences inflammation, Curr. Opin. Immunol., 15, 704, 10.1016/j.coi.2003.09.004 · DOI
- Romano, 2015, FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma, Nucleic Acids Res., 43, 6983, 10.1093/nar/gkv615 · DOI · Paper page
- Romano, 2010, Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells, Cell Death Differ., 17, 145, 10.1038/cdd.2009.115 · DOI
- Luo, 2017, USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling, EMBO J., 36, 1434, 10.15252/embj.201695669 · DOI
- Wang, 2011, FKBP51 regulation of AKT/protein kinase B phosphorylation, Curr. Opin. Pharmacol., 11, 360, 10.1016/j.coph.2011.03.008 · DOI
- Dogan, 2018, Correlation between telomerase and mTOR pathway in cancer stem cells, Gene, 641, 235, 10.1016/j.gene.2017.09.072 · DOI
- Koundouros, 2018, Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer, Front. Oncol., 8, 160, 10.3389/fonc.2018.00160 · DOI · Paper page
- Hausch, 2013, FKBPs and the Akt/mTOR pathway, Cell Cycle, 12, 2366, 10.4161/cc.25508 · DOI
- Baretic, 2014, The structural basis for mTOR function, Semin. Cell Dev. Biol., 36, 91, 10.1016/j.semcdb.2014.09.024 · DOI
- Romano, 2011, The emerging role of large immunophilin FK506 binding protein 51 in cancer, Curr. Med. Chem., 18, 5424, 10.2174/092986711798194333 · DOI
- Zaytseva, 2012, mTOR inhibitors in cancer therapy, Cancer Lett., 319, 1, 10.1016/j.canlet.2012.01.005 · DOI · Paper page
- Liu, 2017, Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells, Oncol. Rep., 38, 271, 10.3892/or.2017.5648 · DOI
- Cazzaniga, 2018, Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged >/= 65 years: New lessons for clinical practice from the EVA study, Oncotarget, 9, 31877, 10.18632/oncotarget.25874 · doi:10.18632/oncotarget.25874
- Hasskarl, 2018, Everolimus, Recent Results Cancer Res., 211, 101, 10.1007/978-3-319-91442-8_8 · DOI
- Gallo, 2011, The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress, J. Biol. Chem., 286, 30152, 10.1074/jbc.M111.256610 · DOI · Paper page
- Akiyama, T., Shiraishi, T., Qin, J., Konno, H., Akiyama, N., Shinzawa, M., Miyauchi, M., Takizawa, N., Yanai, H., and Ohashi, H. (2014). Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN. PLOS ONE, 9. · DOI · Paper page
- Toneatto, 2013, Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation, J. Cell Sci., 126, 5357
- Eisenstein, 2011, Telomeres: All's well that ends well, Nature, 478, S13, 10.1038/478S13a · DOI
- Gomes, 2010, Telomere biology in Metazoa, FEBS Lett., 584, 3741, 10.1016/j.febslet.2010.07.031 · DOI · Paper page
- Shore, 2009, Telomere length regulation: Coupling DNA end processing to feedback regulation of telomerase, EMBO J., 28, 2309, 10.1038/emboj.2009.195 · DOI · Paper page
- Calado, 2009, Telomere diseases, New Engl. J. Med., 361, 2353, 10.1056/NEJMra0903373 · DOI · Paper page
- Masutomi, 2000, Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component, J. Biol. Chem., 275, 22568, 10.1074/jbc.M000622200 · DOI · Paper page
- Forsythe, 2001, Stable association of hsp90 and p23, but Not hsp70, with active human telomerase, J. Biol. Chem., 276, 15571, 10.1074/jbc.C100055200 · DOI · Paper page
- Holt, 1999, Functional requirement of p23 and Hsp90 in telomerase complexes, Genes Dev., 13, 817, 10.1101/gad.13.7.817 · DOI · Paper page
- Yao, 2011, FKBPs in chromatin modification and cancer, Curr. Opin. Pharmacol., 11, 301, 10.1016/j.coph.2011.03.005 · DOI
- Leach, D.A., and Buchanan, G. (2017). Stromal Androgen Receptor in Prostate Cancer Development and Progression. Cancers, 9. · DOI
- Kim, 2012, Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs, J. Immunol., 188, 4226, 10.4049/jimmunol.1103040 · DOI · Paper page
- Li, 2011, The role of FKBP5 in cancer aetiology and chemoresistance, Br. J. Cancer, 104, 19, 10.1038/sj.bjc.6606014 · DOI
- Mukaide, 2008, FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma, Cancer Investig., 26, 385, 10.1080/07357900701799228 · DOI
- Amiri, 2007, Geldanamycin anisimycins activate Rho and stimulate Rho- and ROCK-dependent actin stress fiber formation, Mol. Cancer Res., 5, 933, 10.1158/1541-7786.MCR-06-0362 · DOI
- Houle, 2006, Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor, Mol. Biol. Cell, 17, 3508, 10.1091/mbc.e05-12-1158 · DOI
- Takaoka, 2017, FKBP51 regulates cell motility and invasion via RhoA signaling, Cancer Sci., 108, 380, 10.1111/cas.13153 · DOI
- Ostrow, 2009, Pharmacologic unmasking of epigenetically silenced genes in breast cancer, Clin. Cancer Res., 15, 1184, 10.1158/1078-0432.CCR-08-1304 · DOI
- Pearson, J.D., Mohammed, Z., Bacani, J.T., Lai, R., and Ingham, R.J. (2012). The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein. BMC Cancer, 12. · DOI
- Russo, 2017, A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma, Oncotarget, 8, 68291, 10.18632/oncotarget.19309 · DOI · Paper page
- Wirsching, 2016, Glioblastoma, Handb. Clin. Neurol., 134, 381, 10.1016/B978-0-12-802997-8.00023-2 · DOI · Paper page
- Wang, 2017, Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme, Cell Death Dis., 8, e2807, 10.1038/cddis.2017.217 · DOI
- Ma, 2006, NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with α interferon, Antimicrob. Agents Chemother., 50, 2976, 10.1128/AAC.00310-06 · DOI · Paper page
- Duzgun, 2016, Role of mTOR in glioblastoma, Gene, 575, 187, 10.1016/j.gene.2015.08.060 · DOI
- Donley, 2014, Identification of RBCK1 as a novel regulator of FKBPL: Implications for tumor growth and response to tamoxifen, Oncogene, 33, 3441, 10.1038/onc.2013.306 · DOI
- Nelson, 2015, FKBPL: A marker of good prognosis in breast cancer, Oncotarget, 6, 12209, 10.18632/oncotarget.3528 · DOI
- Renoir, 2012, Estradiol receptors in breast cancer cells: Associated co-factors as targets for new therapeutic approaches, Steroids, 77, 1249, 10.1016/j.steroids.2012.07.019 · DOI
- Renoir, 2013, Estrogen receptor signaling as a target for novel breast cancer therapeutics, Biochem. Pharmacol., 85, 449, 10.1016/j.bcp.2012.10.018 · DOI · Paper page
- Desmetz, 2009, Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women, Clin. Cancer Res., 15, 4733, 10.1158/1078-0432.CCR-08-3307 · DOI
- Dhamad, A.E., Zhou, Z., Zhou, J., and Du, Y. (2016). Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor α (ERα) and Biochemical Characterization of the ERα-Hsp70 Interaction. PLoS ONE, 11. · DOI
- Garifulin, 2015, Application of serex-analysis for identification of human colon cancer antigens, Exp. Oncol., 37, 173, 10.31768/2312-8852.2015.37(3):173-180 · doi:10.31768/2312-8852.2015.37(3):173-180
- Duthie, 2007, Proteomics analysis of interleukin (IL)-7-induced signaling effectors shows selective changes in IL-7Rα449F knock-in T cell progenitors, Mol. Cell. Proteom., 6, 1700, 10.1074/mcp.M600468-MCP200 · DOI
- Quinta, 2011, Management of cytoskeleton architecture by molecular chaperones and immunophilins, Cell Signal., 23, 1907, 10.1016/j.cellsig.2011.07.023 · DOI
- Quinta, 2012, The neuroregenerative mechanism mediated by the Hsp90-binding immunophilin FKBP52 resembles the early steps of neuronal differentiation, Br. J. Pharmacol., 166, 637, 10.1111/j.1476-5381.2011.01783.x · DOI
- Ott, 2015, Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway, Glia, 63, 78, 10.1002/glia.22734 · DOI
- Lim, 2002, Proteome analysis of hepatocellular carcinoma, Biochem. Biophys. Res. Commun., 291, 1031, 10.1006/bbrc.2002.6547 · doi:10.1006/bbrc.2002.6547
- Schulke, J.P., Wochnik, G.M., Lang-Rollin, I., Gassen, N.C., Knapp, R.T., Berning, B., Yassouridis, A., and Rein, T. (2010). Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS ONE, 5. · DOI · Paper page
- Tranguch, 2006, Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation, Reprod. Biomed. Online, 13, 651, 10.1016/S1472-6483(10)60655-4 · DOI
- Lagadari, 2016, Regulation of NF-κB signalling cascade by immunophilins, Curr. Mol. Pharmacol., 9, 99, 10.2174/1874467208666150519113833 · DOI
- Maschi, 2010, Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth, J. Neurochem., 115, 716, 10.1111/j.1471-4159.2010.06970.x · DOI · Paper page
- Jinwal, 2010, The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules, J. Neurosci., 30, 591, 10.1523/JNEUROSCI.4815-09.2010 · DOI · Paper page
- Dai, 2004, A novel role for the immunophilin FKBP52 in copper transport, J. Biol. Chem., 279, 27845, 10.1074/jbc.C400118200 · DOI
- Nguyen, 2013, Hsp90 chaperones PPARgamma and regulates differentiation and survival of 3T3-L1 adipocytes, Cell Death Differ., 20, 1654, 10.1038/cdd.2013.129 · DOI
- Desarzens, S., Liao, W.H., Mammi, C., Caprio, M., and Faresse, N. (2014). Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation. PLoS ONE, 9. · DOI
- Verstraeten, 2011, Reorganization of the nuclear lamina and cytoskeleton in adipogenesis, Histochem. Cell Biol., 135, 251, 10.1007/s00418-011-0792-4 · DOI
- Hetzer, 2006, The role of the nuclear envelope in cellular organization, Cell. Mol. Life Sci., 63, 316, 10.1007/s00018-005-5361-3 · DOI
- Stuurman, 1997, Identification of a conserved phosphorylation site modulating nuclear lamin polymerization, FEBS Lett., 401, 171, 10.1016/S0014-5793(96)01464-0 · doi:10.1016/s0014-5793(96)01464-0
- Stechschulte, 2014, FKBP51 reciprocally regulates GRα and PPARgamma activation via the Akt-p38 pathway, Mol. Endocrinol., 28, 1254, 10.1210/me.2014-1023 · DOI
- Stechschulte, 2014, FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARgamma, Mol. Endocrinol., 28, 1265, 10.1210/me.2014-1022 · DOI
- O'Leary, J.C., Dharia, S., Blair, L.J., Brady, S., Johnson, A.G., Peters, M., Cheung-Flynn, J., Cox, M.B., de Erausquin, G., and Weeber, E.J. (2011). A new anti-depressive strategy for the elderly: Ablation of FKBP5/FKBP51. PLoS ONE, 6. · DOI · Paper page
- Touma, 2011, FK506 binding protein 5 shapes stress responsiveness: Modulation of neuroendocrine reactivity and coping behavior, Biol. Psychiatry, 70, 928, 10.1016/j.biopsych.2011.07.023 · DOI · Paper page
- Hartmann, 2012, The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress, Neuropharmacology, 62, 332, 10.1016/j.neuropharm.2011.07.041 · DOI · Paper page
- Stechschulte, 2016, FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARgamma Agonist Rosiglitazone, Endocrinology, 157, 3888, 10.1210/en.2015-1996 · DOI · Paper page
- Hardwick, 2018, Cell cycle-dependent phosphorylation and regulation of cellular differentiation, Biochem. Soc. Trans., 46, 1083, 10.1042/BST20180276 · DOI
- Scharf, S.H., Liebl, C., Binder, E.B., Schmidt, M.V., and Muller, M.B. (2011). Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS ONE, 6. · DOI · Paper page
- Fries, 2015, The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders, Curr. Mol. Pharmacol., 9, 126, 10.2174/1874467208666150519114435 · DOI
- Paquette, A.G., Lester, B.M., Koestler, D.C., Lesseur, C., Armstrong, D.A., and Marsit, C.J. (2014). Placental FKBP5 genetic and epigenetic variation is associated with infant neurobehavioral outcomes in the RICHS cohort. PLoS ONE, 9. · DOI · Paper page
- Rein, 2018, Hsp90 and FKBP51: Complex regulators of psychiatric diseases, Philos. Trans. R. Soc. Lond. Ser. Biol. Sci., 373, 20160532, 10.1098/rstb.2016.0532 · DOI · Paper page
- Ising, 2008, Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls, Eur. J. Neurosci., 28, 389, 10.1111/j.1460-9568.2008.06332.x · DOI · Paper page
- Mahon, 2013, Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults, Psychopharmacology, 227, 231, 10.1007/s00213-012-2956-x · DOI · Paper page
- Shibuya, 2010, Association study between a functional polymorphism of FK506-binding protein 51 (FKBP5) gene and personality traits in healthy subjects, Neurosci. Lett., 485, 194, 10.1016/j.neulet.2010.09.010 · DOI
- Fani, 2014, FKBP5 genotype and structural integrity of the posterior cingulum, Neuropsychopharmacology, 39, 1206, 10.1038/npp.2013.322 · DOI
- Fani, 2013, FKBP5 and attention bias for threat: Associations with hippocampal function and shape, JAMA Psychiatry, 70, 392, 10.1001/2013.jamapsychiatry.210 · DOI · Paper page
- Fujii, 2014, Association between the common functional FKBP5 variant (rs1360780) and brain structure in a non-clinical population, J. Psychiatr. Res., 58, 96, 10.1016/j.jpsychires.2014.07.009 · DOI
- Szabo, 2013, Association among clinical response, hippocampal volume, and FKBP5 gene expression in individuals with posttraumatic stress disorder receiving cognitive behavioral therapy, Biol. Psychiatry, 74, 793, 10.1016/j.biopsych.2013.05.017 · DOI
- White, 2012, FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity, Genesbrainand Behav., 11, 869
- Pohlmann, 2018, Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs, Front. Behav. Neurosci., 12, 262, 10.3389/fnbeh.2018.00262 · DOI · Paper page
- Gassen, 2015, Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine, Sci. Signal., 8, ra119, 10.1126/scisignal.aac7695 · DOI · Paper page
Cited by
Lee, K., Thwin, A. C., Nadel, C. M., Tse, E., Gates, S. N., Gestwicki, J. E., & Southworth, D. R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.023 · Cited by 76
Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor
Noddings, C. M., Johnson, J. L., & Agard, D. A. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01128-y · Cited by 75
“Notably, Hsp90A W320,F349 also make contact with GR in the GR–loading complex and GR–maturation complex, although at endocrine-related diseases, including cancers, infertility, anxiety disorders and immune-related diseases 21,33,34 .”
BackgroundFKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
Maeda, K., Habara, M., Kawaguchi, M., Matsumoto, H., Hanaki, S., Masaki, T., Sato, Y., Matsuyama, H., Kunieda, K., Nakagawa, H., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13030 · Cited by 32
Peptidylprolylisomerases, Protein Folders, or Scaffolders? The Example of FKBP51 and FKBP52
Rein, T. (2020) · BioEssays · doi:10.1002/bies.201900250 · Cited by 25
Metadata
- Authors
- Zgajnar, N., De Leo, S., Lotufo, C., Erlejman, A., Piwien-Pilipuk, G., & Galigniana, M.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-02-01
- Volume
- 9
- Issue
- 2
- Pages
- 52
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W2912308905
- Cited by
- 94
- References
- 56
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.